Genes and cancer

MedicaMundi

Volumn 47, Issue 1, 2003, Pages 28-33

  Cornelisse, C J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58349114666     PISSN: 00257664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Hahn WC, Weinberg RA. Modelling the Molecular Circuitry of Cancer. Nat Rev Cancer 2002; 2: 331-341.
2. Boveri, T. Zur Frage der Entstehung maligner Tumoren. 1914. Jena, Gustav Fischer.
3. Nowell PC, Hungerford D. A Minute Chromosome in Human Granulocytic Leukemia. Science 1960; 132: 1497.
4. Rowley JD. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukemia. Nature 1973; 243: 290-293.
5. De Klein A, Van Kessel AG, Grosveld G et al. A Cellular Oncogene is Translocated to the Philadelphia Chromosome in Chronic Myelocytic Leukaemia. Nature 1982; 300: 765-767.
6. Stehelin D, Varmus HE, Bishop JM, Vogt PK. DNA Related to the Transforming Gene(s) of Avian Sarcoma Viruses is Present in Normal Avian DNA. Nature 1976: 260: 170-173.
7. Heisterkamp N, Stephenson JR, Groffen J et al. Localization of the c-ab1 Oncogene adjacent to a Translocation Break Point in Chronic Myelocytic Leukaemia. Nature 1983; 306: 239-242.
8. Druker BJ, Tamura S, Buchdunger E et al. Effects of a Selective Inhibitor of the Abl Tyrosine Kinase on the Growth of Bcr-Abl Positive Cells. Nat Med 1996; 2: 561-566.
9. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, Mcguire WL. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/Neu Oncogene. Science 1987; 235: 177-182.
10. Van de Vijver M, Van de Bersselaar R, Devilee P, Cornelisse C, Peterse J, Nusse R. Amplification of the neu (c-erbB-2) Oncogene in Human Mammary Tumors is Relatively Frequent and is often accompanied by Amplification of the Linked c-erbA Oncogene. Mol Cell Biol 1987; 7: 2019-2023.
11. Slamon DJ, Leyland-Jones B, Shak S et al. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer that Overexpresses HER2. N Engl J Med 2001; 344: 783-792.
12. Nowell PC. The Clonal Evolution of Tumor Cell Populations. Science 1976; 194: 23-28.
13. Kinzler KW, Vogelstein B. Lessons from Hereditary Colorectal Cancer. Cell 1996; 87: 159-170.
14. Knudson AG Jr. Mutation and Cancer: Statistical Study of Retinoblastoma. Proc Natl Acad Sci U S A 1971; 68: 820-823.
15. Friend SH, Bernards R, Rogelj S et al. A Human DNA Segment with Properties of the Gene that Predisposes to Retinoblastoma and Osteosarcoma. Nature 1986; 323: 643-646.
16. Hall JM, Lee MK, Newman B et al. Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21. Science 1990; 250: 1684-1689.
17. Miki Y, Swensen J, Shattuck-Eidens D et al. A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1. Science 1994; 266: 66-71.
18. Wooster R, Bignell G, Lancaster J et al. Identification of the Breast Cancer Susceptibility Gene BRCA2. Nature 1995; 378: 789-792.
19. Ford D, Easton DF, Stratton M et al. Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-689.
20. Meijers-Heijboer H, Van Geel B, Van Putten WL et al. Breast Cancer after Prophylactic Bilateral Mastectomy in Women with A BRCA1 or BRCA2 Mutation. N Engl J Med 2001; 345: 159-164.
21. Tilanus-Linthorst M, Verhoog L, Obdeijn IM et al. A BRCA1/2 Mutation, High Breast Density and Prominent Pushing Margins of a Tumor Independently Contribute to a Frequent False-Negative Mammography. Int J Cancer 2002, 102: 91-95.
22. Kuhl CK, Schmutzler RK, Leutner CC et al. Breast MR Imaging Screening in 192 Women Proved or Suspected to be Carriers of a Breast Cancer Susceptibility Gene: Preliminary Results. Radiology 2000; 215: 267-279.
23. Warner E, Plewes DB, Shumak RS et al. Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer. J Clin Oncol 2001; 19: 3524-3531.
24. Van 't Veer LJ, Dai H, Van De Vijver MJ et al. Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer. Nature 2002; 415: 530-536.